E. I. duPont de Nemours & Company - SWOT Analysis
Datamonitor's E. I. duPont de Nemours & Company - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
E.I. du Pont de Nemours & Company (DuPont) is a diversified company offering products and services for various markets, including agriculture, nutrition, electronics and communications, safety and protection, home and construction, transportation, and apparel. The company primarily operates in the North America, Latin America, Europe, and Asia Pacific. It is headquartered in Wilmington, Delaware, and employs about 60,000 people. The company recorded revenues of $30,653 million in the financial year ended December 2007 (FY2007), an increase of 5.8% over the financial year ended December 2006 (FY2006). The operating profit of the company was $27,340 million in the FY2007, an increase of 4.7% over FY2006. The net profit was $2,988 million in the FY2007, a decrease of 5.1% compared with FY2006.
Scope of the Report
- Provides all the crucial company information required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement
Reasons to Purchase
- Support sales activities by understanding your customers’ businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available
RELATED REPORTS
Datamonitor's Cerner Corporation - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. ...
Industries : Healthcare
Datamonitor's Bayer AG - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. Bayer is a ...
Industries : Healthcare
Datamonitor's CVS Caremark Corporation - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and stra ...
Industries : Healthcare
Datamonitor's ViroPharma Incorporated - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strat ...
Industries : Healthcare
Snapdata's Snapshots US Healthcare Services 2008 provides 2007 year-end market size data, with 2008 estimates, 5 years of historical data and five-year forecasts. The Snapshots report gives an instant overview of the US healthcare service market and covers government-funded, private payments, privat ...
Industries : Healthcare
Datamonitor's Cubist Pharmaceuticals, Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and ...
Industries : Healthcare
IntroductionDatamonitor expects the antihypertensives market to reach $37 billion, across the seven major markets, by 2017. The growth will be driven by the uptake of Novartis's Tekturna, as well as increased use of ARBs, and their combinations. However, the expiries of some key patents, particularl ...
Industries : Healthcare
IntroductionIn 2008, the six tumor types covered in this report are forecast to account for over 666,000 new cases of cancer, obviously representing an enormous market potential. However, it is the higher-incidence tumor types that continue to attract drug developers, with lower-incidence cancers po ...
Industries : Healthcare
IntroductionThis analysis examines the historical and forecast performance for Pfizer in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An intera ...
Industries : Healthcare
SynopsisAnalysis and opinion on monthly deal activity, along with the trend for the last six months for merger and acquisition (M&A), private equity, private placement, IPO, and secondary offering deals.IntroductionThis report contains extensive qualitative and quantitative analysis of monthly deal ...
Industries : Healthcare
Related industries
reportlinker.com © Copyright 2009. All rights reserved